Affimed AFMD will release its quarterly earnings report on Thursday, 2024-11-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Affimed to report an earnings per share (EPS) of $-1.05.
The market awaits Affimed's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
In the previous earnings release, the company missed EPS by $0.11, leading to a 0.79% drop in the share price the following trading session.
Here's a look at Affimed's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.980 | -1.540 | -1.67 | -2 |
| EPS Actual | -1.087 | -1.379 | -1.50 | -1.7 |
| Price Change % | -1.0% | 3.0% | -1.0% | 20.0% |
Tracking Affimed's Stock Performance
Shares of Affimed were trading at $3.76 as of November 11. Over the last 52-week period, shares are up 1.62%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Affimed visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
